CD56 (NCAM1), expressed in neural stem cells and natural killer cells, is similarly overexpressed in GBM, contributing to chemoresistance and poor prognosis, and is found on exosomes, where it may modulate immune responses [45,76,77]. The gene discussed is NCAM1; the disease is glioblastoma.